Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026


Go back to Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

Boston Scientific (BSX) Commences Study of Resorbable Drug-Eluting Scaffold System

July 20, 2015 9:02 AM UTC

Boston Scientific (NYSE: BSX) has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully Absorbable Scaffold Feasibility Study (FAST) is a prospective, single arm study designed to assess the safety and performance of this next generation scaffold for the treatment of atherosclerotic coronary lesions.

The first patients in the study were enrolled by Professor Ian Meredith, primary... More